Filing metadata

Accession number
0001209191-23-032679
Form type
Form 4
Filer
Quince Therapeutics, Inc.
CIK
CIK 1662774
Filed
May 26, 2023
Reporting period
May 24, 2023
Description
Insider transaction

Explore SEC Filings Hub